Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chidan
- Development stage
- Unknown
- Lead developer
- Peking University Shijia Technology Development
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Chidan (also known as Chidan capsule) is a botanical drug candidate developed by Peking University Shijia Technology Development for the treatment of type 2 diabetes mellitus. It is classified as a Traditional Chinese Medicine (TCM) new drug. Formulated as an oral capsule, Chidan has undergone Phase 1 clinical evaluation in China (e.g., trial CTR20132543) to assess its safety, tolerability, and pharmacokinetic profile in healthy adult volunteers. As a botanical product derived from herbal sources, its therapeutic mechanism likely involves multi-target modulation of glucose metabolism and insulin signaling pathways, although specific molecular targets have not been definitively characterized in public clinical registries.
- Other names
- Chidan capsule赤丹胶囊
Beyond the preview
Go deeper on Chidan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chidan.